Does DILTIAZEM Cause Hepatocellular injury? 22 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hepatocellular injury have been filed in association with DILTIAZEM (Cardizem CD). This represents 0.2% of all adverse event reports for DILTIAZEM.
22
Reports of Hepatocellular injury with DILTIAZEM
0.2%
of all DILTIAZEM reports
4
Deaths
10
Hospitalizations
How Dangerous Is Hepatocellular injury From DILTIAZEM?
Of the 22 reports, 4 (18.2%) resulted in death, 10 (45.5%) required hospitalization, and 3 (13.6%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DILTIAZEM. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does DILTIAZEM Cause?
Completed suicide (1,696)
Toxicity to various agents (1,663)
Hypotension (1,550)
Dyspnoea (1,436)
Drug ineffective (1,315)
Fall (1,262)
Pain (1,169)
Dizziness (1,091)
Fatigue (1,054)
Headache (874)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which DILTIAZEM Alternatives Have Lower Hepatocellular injury Risk?
DILTIAZEM vs DIMENHYDRINATE
DILTIAZEM vs DIMETHICONE
DILTIAZEM vs DIMETHICONE\LOPERAMIDE
DILTIAZEM vs DIMETHINDENE
DILTIAZEM vs DIMETHYL